The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft ModelsWenyu Hu, Nanlin Li|Breast Cancer Targets and Therapy|2023Cited by 4
HGH1 Promotes Breast Cancer Progression Through the PI3K/AKT/NF-κB Signaling Pathway: Potential Role for Prognosis and Targeted TherapyWenyu Hu, Nanlin Li|Breast Cancer Targets and Therapy|2025Cited by 2
Abstract PO1-27-01: Comparing the Efficacy and Safety of TQB2440 versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 TrialQingyuan Zhang, Qingshan Li, Jianjun Huang et al.|Cancer Research|2024Cited by 0